Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study

Clinical Rheumatology

Volumn 31, Issue 8, 2012, Pages 1187-1196

  Migliore, Alberto ^a   Bella, Antonino ^b   Bisignani, Massimariano ^c   Calderaro, Michele ^a   De Amicis, Daniele ^d   Logroscino, Giandomenico ^e   Mariottini, Fabio ^f   Moreschini, Oreste ^g   Massafra, Umberto ^a   Bizzi, Emanuele ^a   Laganà, Bruno ^g   Piscitelli, Prisco ^h   Tormenta, Sandro ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CTO Hospital ASL Roma C   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f Italian Society of Orthopedics and Traumatology   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h ISBEM   (Italy)

Author keywords

Hip; Hyaluronic acid; Intra articular injection; Osteoarthritis; Ultrasound guidance

Indexed keywords

HYALONE; HYALURONIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SURVIVAL; TOTAL HIP PROSTHESIS; ULTRASOUND;

EID: 84866004786     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-1994-4     Document Type: Article

References (37)

1. Lawrence RC, Helmick CG, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41(5):778-799
2. Zhang W, Doherty M, Arden N, et al (2005) EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence-based recommendations for the management of hip osteoarthritis: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669-681. Available at: Http://ard.bmj.com/content/64/5/669.full.pdf. Accessed Oct 7 2004
3. Sperati A, Picconi O, Tancioni V, Guasticchi G, Agabiti N (2008) Outcomes of hip replacement: A hospital-based longitudinal study in Lazio region. Ann Ig 20(2):141-157
4. Bagge E, Bjelle A, Valkenburg H et al (1992) Prevalence of radiographic osteoarthritis in two elderly European populations. Rheumatol Int 12:33-38
5. Goldberg VM, Kettelkamp DB, Colyer RA (1992) Osteoarthritis of the knee. In:Moskowitz RW, Howell DS, Goldberg VM, HJMankin HJ (eds) Osteoarthritis: Diagnosis and medical/surgical management. WB Saunders, Philadelphia, pp 599-620
6. Poole AR (1995) Imbalances of anabolism and catabolism of cartilage matrix components in osteoarthritis. In: Kuettner K, Goldberg V (eds) Osteoarthritic disorders. American Academy of Orthopedic Surgeons, Rosemont, pp 247-260
7. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendation for the medical management of osteoarthritis of hip and knee: 2000 update. Arthritis Rheum 43:1905-1915
8. Moskowitz RW (2001) Osteoarthritis: Simple analgesics versus nonsteroidal anti-inflammatory drugs. J Rheumatol 28:932-934
9. Balazs EA, Denlinger JL (1993) Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 20(39):2-9
10. Adams ME, Atkinson MH, Lussier AJ et al (1995) The role of viscosupplementation with Hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing Hylan G-F 20 alone, Hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3:213-226
11. Marshall KW (1997) The current status of hylan therapy for the treatment of osteoarthritis. Today's Ther Trends 15:99-108
12. Gabriel SE (1996) Update on the epidemiology of the rheumatic diseases. Curr Opinion Rheum 8:96-100
13. Vinciguera C, Gueguen A, Revel M et al (1995) Predictors of the need for total hip replacement in patients with osteoarthritis of the hip. Rev Rhum (Engl Ed) 62:563-570
14. Qvistgaard E, Kristoffersen H, Terslev L et al (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthr Cartil 9:512-517
15. Migliore A, Martin Martin LS, Alimonti A et al (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intraarticular injection in osteoarthritis of the hip. Osteoarthr Cartil 11:305-306
16. Brocq O, Tran G, Breuil U et al (2002) Hip osteoarthritis: Short term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69(4):388-391
17. Conrozier T, Bertin P, Mathieu P et al (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: An open label, multicentre, pilot study. Clin Exp Rheumato 21:605-610
18. Jaimes-Hernandez J, Suarez-Otero R, Rosas-Ramos R, et al Change in coxofemoral joint interlines after the application of hylan gf-20 in patients with coxarthrosis M., AB0454 ACR 2002
19. Kellgren JK, Lawrence JS (1957) Radiological assessment of osteoarthritis. Ann Rheum Dis 15:494-501
20. Altman RD, Hochberg MC, Moskowitz RW et al (2000) Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43:1905-1915
21. Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatology 24:779-781
22. Migliore A, Massafra U, Iannessi F, et al (2006) Efficacy and safety of Hyalubrix® administration in hip osteoarthritis: Prospective cohort study. Ann Rheum Dis: 65
23. Migliore A, Bizzi E, Massafra U et al (2008) 18 months follow-up after intra-articular administration of hyalubrix® in 344 patients with symptomatic osteoarthritis of the hip. Osteoarthr Cartil 16: S118-S119
24. Migliore A, Massafra U, Bizzi E, et al (2009) Comparative, doubleblind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 11(6):R183. http://www.ncbi.nlm.nih.gov/pubmed/20003205. Accessed Dec 9 2009. PMID: 20003205
25. Migliore A, Massafra U, Bizzi E et al. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: A prospective cohort study. Arch Orthop Trauma Surg 131(12):1677-1685
26. Altman R, Alarcon G, Appelrouth D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34(5):505-514
27. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494-502
28. Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779-781
29. Van den BekeromMP, Lamme B, Sermon A, et al (2008)What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg 128(8):815-823. http://www.ncbi.nlm.nih.gov/pubmed/17874246. Accessed Sep 15 2007. PMID: 17874246
30. Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16:137-162
31. Leopold SS, Battista V, Oliverio JA (2001) Safety and efficacy of intra-articular hip injection using anatomic landmarks. Clin Orthop (391):192-197
32. Diraçoǧlu D, Alptekin K, Dikici F, Balci HI, Ozçakar L, Aksoy C (2009) Evaluation of needle positioning during blind intra-articular hip injections for osteoarthritis: Fluoroscopy versus arthrography. Arch Phys Med Rehabil 90(12):2112-2115
33. Gonçalves B, Ambrosio C, Serra S, Alves F, Gil-Agostinho A, Caseiro-Alves F (2011) US-guided interventional joint procedures in patients with rheumatic diseases -When and how we do it? Eur J Radiol 79(3):407-414
34. Chevalier X, Henrotin Y (2009) Osteoarthritis Committee of the French Society for Rheumatology. OARSI recommendations on knee and hip osteoarthritis: Use with discernment. Joint Bone Spine 76(5):455-457
35. Zhang W, Nuki G, Moskowitz RW et al (2010) OARSI recommendations for the management of hip and knee osteoarthritis Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 18:476-499
36. Straube S, Tramèr MR, Moore RA et al (2009) Mortality with upper gastrointestinal bleeding and perforation: Effects of time and NSAID use. BMC Gastroenterol 9:41
37. Oliveria SA, Felson DT, Reed JI et al (1995) Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 38:1134-1141